Marksans Pharma Limited — Fluoxetine Exporter Profile
Indian Pharmaceutical Exporter · #7 for Fluoxetine · $5.6M export value · DGFT Verified
Marksans Pharma Limited is the #7 Indian exporter of Fluoxetine with $5.6M in export value and 168 verified shipments. Marksans Pharma Limited holds a 2.4% market share in Fluoxetine exports across 3 countries. The company exports 22 pharmaceutical products worth $125.0M across 11 therapeutic categories.
Marksans Pharma Limited — Fluoxetine Export Profile: Buyers & Destinations
Where Does Marksans Pharma Limited Export Fluoxetine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $3.9M | 114 | 79.7% |
| UNITED KINGDOM | $964.7K | 51 | 19.9% |
| IRAQ | $18.6K | 3 | 0.4% |
Marksans Pharma Limited exports Fluoxetine to 3 countries. The largest destination is UNITED STATES accounting for 79.7% of Marksans Pharma Limited's Fluoxetine shipments, followed by UNITED KINGDOM (19.9%) and IRAQ (0.4%). These destinations reflect Marksans Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Fluoxetine from Marksans Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TIME-CAP LABS, | UNITED STATES | $2.2M | 62 |
| RELONCHEM LTD | UNITED KINGDOM | $598.8K | 38 |
| TIME-CAP LABS, INC | UNITED STATES | $557.9K | 19 |
| TIME-CAP LABS INC | UNITED STATES | $531.2K | 17 |
| TIME CAP LABS | UNITED STATES | $280.8K | 7 |
| RELONCHEM LTD CHESHIRE HOUSE | UNITED KINGDOM | $196.4K | 5 |
| TIME-CAP LABS | UNITED STATES | $179.3K | 6 |
| RELONCHEM LTD CHESHIRE HOUSE, | UNITED KINGDOM | $169.5K | 8 |
| TIME-CAP LABS, INC., | UNITED STATES | $42.6K | 1 |
| DUOPHARMA SCIENTIFIC BUREAU | IRAQ | $18.6K | 3 |
Marksans Pharma Limited supplies Fluoxetine to 12 buyers globally. The largest buyer is TIME-CAP LABS, (UNITED STATES), followed by RELONCHEM LTD (UNITED KINGDOM) and TIME-CAP LABS, INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Fluoxetine Export Value and How Much Does Marksans Pharma Limited Contribute?
India exported $59.0M worth of Fluoxetine through 3,702 shipments from 253 suppliers to 101 countries, serving 522 buyers globally. Marksans Pharma Limited contributes $5.6M to this total, accounting for 2.4% of India's Fluoxetine exports. Marksans Pharma Limited ships Fluoxetine to 3 countries through 12 buyers.
What Is the Average Shipment Value for Marksans Pharma Limited's Fluoxetine Exports?
Marksans Pharma Limited's average Fluoxetine shipment value is $33.3K per consignment, based on 168 shipments totaling $5.6M. The largest destination is UNITED STATES (79.7% of Marksans Pharma Limited's Fluoxetine exports).
How Does Marksans Pharma Limited Compare to Other Indian Fluoxetine Exporters?
Marksans Pharma Limited ranks #7 among 253 Indian Fluoxetine exporters with a 2.4% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($10.9M), MICRO LABS LIMITED ($7.7M), ALEMBIC PHARMACEUTICALS LIMITED ($5.8M). Marksans Pharma Limited processed 168 shipments to 3 destination countries.
What Fluoxetine Formulations Does Marksans Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS-FLUOXETINE CAPSU | $1.1M | 30 |
| PHARMACEUTICAL PRODUCTS-FLUOXETINE 20MG | $259.6K | 18 |
| FLUOXETINE CAPSULES USP 20MG BATCH NO: 2 | $230.8K | 6 |
| FLUOXETINE 20MG CAPSULES BATCH NO: 22036 | $62.8K | 2 |
| FLUOXETINE CAPSULES USP 40MG Batch No: 2 | $55.2K | 2 |
| PHARMACEUTICAL PRODUCTS - FLUOXETINE CAPSULES USP 40MG Batch No: 250049 | $52.5K | 2 |
| FLUOXETINE CAPSULES USP 40MG (4164000 Ca | $50.0K | 1 |
| FLUOXETINE CAPSULES USP 40MG 4320000 Ca | $50.0K | 1 |
| FLUOXETINE CAPSULES USP 40MG BATCH NO: 2 | $50.0K | 1 |
| PHARMACEUTICAL PRODUCTS-FLUOXETINE CAPSULES USP 20MG Batch No: 230389 | $50.0K | 1 |
Marksans Pharma Limited exports 111 distinct Fluoxetine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL PRODUCTS-FLUOXETINE CAPSU with 30 shipments worth $1.1M.
Regulatory Requirements: Exporting Fluoxetine to Key Markets
What Marksans Pharma Limited must comply with to export Fluoxetine to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Marksans Pharma Limited Compare to Nearest Fluoxetine Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | MICRO LABS LIMITED | $7.7M | 154 | 16 | $50.0K |
| 6 | ALEMBIC PHARMACEUTICALS LIMITED | $5.8M | 261 | 2 | $22.1K |
| 7 | MARKSANS PHARMA LIMITED ★ | $5.6M | 168 | 3 | $33.3K |
| 1 | SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED | $5.0M | 99 | 1 | $50.0K |
| 2 | INTAS PHARMACEUTICALS LIMITED | $4.8M | 97 | 7 | $50.0K |
Marksans Pharma Limited ranks #7 among 253 Indian Fluoxetine exporters. Average shipment value of $33.3K compared to the market average of $233.1K. The closest competitors by value are MICRO LABS LIMITED and ALEMBIC PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Fluoxetine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 603 | 16.3% |
| SAHAR AIR | 508 | 13.7% |
| NHAVA SHEVA SEA (INNSA1) | 285 | 7.7% |
| MUNDRA SEA | 150 | 4.1% |
| MUNDRA SEA (INMUN1) | 129 | 3.5% |
| Bombay Air | 119 | 3.2% |
| DELHI AIR | 110 | 3.0% |
| HYDERABAD ICD (INSNF6) | 108 | 2.9% |
What Other CNS & Psychiatric Products Does Marksans Pharma Limited Export?
Marksans Pharma Limited also exports these cns & psychiatric products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Marksans Pharma Limited's Fluoxetine Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Marksans Pharma. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, a crucial maritime route for trade between Asia and Europe. Major shipping lines have introduced an 'Emergency Risk Surcharge' ranging from $250 to $500 per TEU for cargo transiting the Bab-el-Mandeb Strait, effective February 2025. This surcharge elevates shipping costs, potentially impacting the competitiveness of Indian pharmaceutical exports to European and US East Coast markets. (sgeexport.com)
Conversely, the India–European Union Free Trade Agreement (FTA), concluded in January 2026, offers a silver lining. The FTA eliminates tariffs on Indian pharmaceuticals, APIs, vaccines, and medical devices, providing immediate cost relief and enhancing market access for Indian exporters. This development positions Marksans Pharma favorably to increase its footprint in the European market, leveraging its existing regulatory approvals and manufacturing capabilities. (en.wikipedia.org)
Marksans Pharma Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for pharmaceutical exporters. Marksans Pharma has demonstrated a strong commitment to regulatory compliance. In November 2025, the company's Goa facility underwent a current Good Manufacturing Practice (cGMP) inspection by the US FDA, concluding with zero Form 483 observations. This outcome reflects Marksans' dedication to adhering to international quality standards and regulatory requirements. (capitalmarket.com)
Furthermore, the company's subsidiaries have achieved significant regulatory milestones. Time-Cap Laboratories Inc., Marksans' US subsidiary, received an Establishment Inspection Report (EIR) from the US FDA for its New York-based facility in June 2025, following an inspection that resulted in only one observation with no data integrity issues. Such achievements bolster Marksans' reputation as a reliable and compliant pharmaceutical manufacturer. (business-standard.com)
About Marksans Pharma Limited
Marksans Pharma Limited exports 22 products worth $125.0M. Beyond Fluoxetine, top products include Ibuprofen, Amino, Gabapentin, Acetaminophen, Loratadine. View the complete Marksans Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fluoxetine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fluoxetine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Marksans Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 168 individual customs records matching Marksans Pharma Limited exporting Fluoxetine, covering 111 formulations to 3 countries via 12 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 101+ countries, 522+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fluoxetine Export Data from Marksans Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Marksans Pharma Limited's Fluoxetine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Marksans Pharma Limited
Full Company Profile →
22 products · $125.0M total trade · 11 categories
Fluoxetine Stats
Company Overview
Top Products by Marksans Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Marksans Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluoxetine. For current shipment-level data, contact TransData Nexus.